VALSECCHI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 38.439
EU - Europa 17.817
AS - Asia 7.425
SA - Sud America 287
AF - Africa 90
Continente sconosciuto - Info sul continente non disponibili 47
OC - Oceania 38
Totale 64.143
Nazione #
US - Stati Uniti d'America 37.716
IT - Italia 4.120
DE - Germania 2.947
CN - Cina 2.698
SG - Singapore 2.608
SE - Svezia 2.500
IE - Irlanda 2.259
RU - Federazione Russa 1.744
UA - Ucraina 1.467
GB - Regno Unito 878
HK - Hong Kong 847
CA - Canada 635
FI - Finlandia 449
FR - Francia 333
AT - Austria 309
IN - India 302
VN - Vietnam 296
ID - Indonesia 259
DK - Danimarca 179
NL - Olanda 165
TR - Turchia 147
BR - Brasile 123
BE - Belgio 114
JP - Giappone 79
MX - Messico 70
ES - Italia 65
PT - Portogallo 51
IR - Iran 47
CZ - Repubblica Ceca 44
AR - Argentina 42
EU - Europa 40
EC - Ecuador 39
CH - Svizzera 34
PE - Perù 34
KR - Corea 28
RO - Romania 28
CL - Cile 27
AU - Australia 26
EG - Egitto 26
PL - Polonia 20
GR - Grecia 19
TW - Taiwan 16
NO - Norvegia 15
CO - Colombia 13
RS - Serbia 13
BG - Bulgaria 12
IL - Israele 12
NZ - Nuova Zelanda 12
PH - Filippine 12
SC - Seychelles 12
TH - Thailandia 12
ZA - Sudafrica 12
MY - Malesia 10
PK - Pakistan 9
SK - Slovacchia (Repubblica Slovacca) 9
LT - Lituania 8
MA - Marocco 8
NG - Nigeria 8
ET - Etiopia 7
BD - Bangladesh 6
UY - Uruguay 6
AL - Albania 5
PA - Panama 5
QA - Qatar 5
SA - Arabia Saudita 5
BB - Barbados 4
HU - Ungheria 4
LU - Lussemburgo 4
LV - Lettonia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
DZ - Algeria 3
GT - Guatemala 3
HR - Croazia 3
NP - Nepal 3
SI - Slovenia 3
TN - Tunisia 3
UZ - Uzbekistan 3
A1 - Anonimo 2
AZ - Azerbaigian 2
CR - Costa Rica 2
EE - Estonia 2
GE - Georgia 2
GH - Ghana 2
IQ - Iraq 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
MM - Myanmar 2
MU - Mauritius 2
PY - Paraguay 2
TC - Turks e Caicos 2
TG - Togo 2
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BZ - Belize 1
CI - Costa d'Avorio 1
GL - Groenlandia 1
Totale 64.128
Città #
Ann Arbor 8.079
Woodbridge 3.778
Fairfield 3.302
Chandler 2.501
Houston 2.436
Dublin 2.183
Singapore 2.161
Frankfurt am Main 2.145
Ashburn 1.816
Wilmington 1.749
Jacksonville 1.588
Seattle 1.275
Cambridge 1.147
Milan 1.096
Dearborn 1.046
New York 974
Santa Clara 864
Princeton 846
Hong Kong 827
Nanjing 474
Altamura 403
Lawrence 397
Shanghai 366
Beijing 319
Vienna 288
Lachine 269
Jakarta 255
San Diego 202
Boardman 171
Helsinki 157
Guangzhou 156
Nanchang 155
Andover 134
Toronto 127
London 122
Chicago 116
Shenyang 116
Dong Ket 113
Lissone 113
Ottawa 113
Rome 112
Hebei 108
Tianjin 103
Brussels 96
Changsha 87
Jinan 82
Norwalk 82
Falls Church 78
Mountain View 76
Fremont 74
Jiaxing 72
Huizen 67
Los Angeles 67
Redmond 51
Bologna 49
Monza 49
Ningbo 47
Montréal 44
Edmonton 43
Florence 42
Hangzhou 42
Zhengzhou 42
Pune 40
Kunming 35
Paris 35
Dallas 34
Washington 34
Munich 33
Kocaeli 31
Sacramento 31
Turin 30
Hefei 28
Palermo 28
Taizhou 28
Brno 27
Leawood 26
Nürnberg 26
University Park 26
Padova 25
Torino 25
Bergamo 24
Fuzhou 24
San Mateo 24
Chengdu 23
Lima 23
Auburn Hills 21
Hanoi 21
Naples 21
Como 20
Amsterdam 19
Ardea 19
Boston 19
Grafing 19
Kiev 19
Melzo 19
Mumbai 19
São Paulo 19
Verona 19
Carate Brianza 18
Perugia 18
Totale 46.842
Nome #
New concepts on the clinical course and stratification of compensated and decompensated cirrhosis 790
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 366
Clinical states of cirrhosis and competing risks 351
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 346
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients 340
The SIPI for measuring complexity in nursing care: Evaluation study 320
Effects of antenatal indomethacin on ductus arteriosus early closure and on adverse outcomes in preterm neonates 318
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib 310
Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years 309
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 304
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 298
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 288
Nomograms to identify elevated blood pressure values and left ventricular hypertrophy in a paediatric population: American Academy of Pediatrics Clinical Practice vs. Fourth Report/European Society of Hypertension Guidelines 280
Glutamine-enriched intravenous total parenteral nutrition doesn't improve mucositis and clinical outcome after stem cell transplantation for childhood malignancies. A prospective double- blind controlled study on behalf of AIEOP Group 277
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 277
Modeling the hazard of transition into the absorbing state in the illness-death model 271
Noninvasive Ventilatory Support of COVID-19 Patients Outside the Intensive Care Units (WARd-COVID) 271
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 271
Imatinib long term effects study: three years of follow-up and assessment 269
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry 269
Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis 267
Joint model robustness compared with the time-varying covariate Cox model to evaluate the association between a longitudinal marker and a time-to-event endpoint 265
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells 263
A new prognostic index of severity of intellectual disabilities in Cornelia de Lange syndrome 262
Study protocol: understanding the pathophysiologic mechanisms underlying delirium in older people undergoing hip fracture surgery 262
Graphical representations and summary indicators to assess the performance of risk predictors 255
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 253
The relationship between frailty and delirium: insights from the 2017 Delirium Day study 249
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 245
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 244
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 244
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 243
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 240
Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale 239
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 237
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 233
Three-year National report from the Gruppo Italiano di Ortogeriatria (GIOG) in the management of hip-fractured patients 233
How do self-care maintenance, self-care monitoring, and self-care management affect glycated haemoglobin in adults with type 2 diabetes? A multicentre observational study 233
Impact of Continuous vs Bolus Feeding on Splanchnic Perfusion in Very Low Birth Weight Infants: A Randomized Trial 232
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 230
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 229
Factors Influencing Access to Transplant, Waitlist Mortality, and Post-Transplant Survival in the Italian National Heart Transplant Database 225
Multi-center randomized controlled trial on the effect of triclosan-coated sutures on surgical site infection after colorectal surgery 224
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 223
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study 223
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 223
Carotid plaque echolucency increases the risk of stroke in carotid stenting: The imaging in carotid angioplasty and risk of stroke (ICAROS) study 221
Effects of lifestyle modifications on elevated blood pressure and excess weight in a population of Italian children and adolescents 220
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 220
Effectiveness of treatments for acute and sub-acute mechanical non-specific low back pain: Protocol for a systematic review and network meta-analysis 220
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 219
Complexity of nursing care at 24 h from admission predicts in-hospital mortality in medical units: A cohort study 219
Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases 217
Body temperature at nursery admission in a cohort of healthy newborn infants: Results from an observational cross-sectional study 217
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 216
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 216
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 214
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL 214
Sudden death and associated factors in a historical cohort of chronic haemodialysis patients 212
Modelling the hazard of transition into the absorbing state in the illness-death model 204
Survival probabilities with time-dependent treatment indicator: Quantities and non-parametric estimators 203
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 203
Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach 201
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results 200
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 196
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 196
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 196
A second update on mapping the human genetic architecture of COVID-19 195
Maternal polymorphisms for methyltetrahydrofolate reductase and methionine synthetase reductase and risk of children with Down syndrome 195
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia 195
Usefulness of waist circumference for the identification of childhood hypertension 194
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 193
Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response 193
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 192
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 192
Prevalence of atrial fibrillation and associated factors in a population of long-term hemodialysis patients 191
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 191
Delirium in Patients with SARS‐CoV‐2 Infection: A Multicenter Study 190
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome 189
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 189
Health Related Quality of Life in the Major Liver Conditions 186
Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients 186
A randomized and controlled study of noninvasive hemodynamicmonitoring as a guide to drug treatment of uncontrolled hypertensive patients 186
Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy 186
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 185
Indicators based on registers and administrative data for breast cancer: Routine evaluation of oncologic care pathway can be implemented 185
Clinico-biologic features of 5202 acute lymphoblastic leukemia patients enrolled in the Italian AIEOP and GIMEMA Protocols and stratified in age-cohorts 183
Multivariate permutation test to compare survival curves for matched data 183
Increased serum uric acid levels blunt the antihypertensive efficacy of lifestyle modifications in children at cardiovascular risk 183
Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation 182
Dexamethasone vs prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000 182
Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases 180
Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNoms study 180
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia". 180
Robust non parametric one-sample tests for the analysis of recurrent events 179
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 179
Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study 179
The impact of liver disease on the health-related quality of life 178
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: A randomised controlled trial protocol 178
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study 178
Totale 23.362
Categoria #
all - tutte 236.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 236.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.017 0 0 0 0 0 1.272 1.410 756 1.025 590 694 270
2020/20219.613 549 494 932 1.006 688 906 980 891 775 1.001 616 775
2021/20226.287 477 642 716 586 427 468 335 313 373 432 527 991
2022/202310.905 1.185 3.076 925 1.011 813 1.669 154 611 733 116 376 236
2023/20247.578 261 257 385 471 979 1.850 1.398 247 571 209 148 802
2024/20257.643 1.112 2.045 1.243 924 1.539 780 0 0 0 0 0 0
Totale 66.326